Pulmonary Embolism WArsaw REgistry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Initiated in January 2008, The PE-aWARE (Pulmonary Embolism WArsaw REgistry) is an on-going single-centre prospective observational study of patients with confirmed acute pulmonary embolism (APE). Extensive data on consecutive patients with pulmonary embolism is collected and stored. The main objective is to collect and provide information on patients' characteristics, management, and outcome with the purpose of decreasing mortality in APE, the occurrence of bleeding, and the frequency of thromboembolic recurrences. Moreover, the PE-aWARE registry serves as a basis for creating predictive scores for clinicians which aid patient management. The study endpoints comprise clinically recognized (and objectively confirmed) recurrences of PE, major and minor bleeding complications classified according to the International Society on Thrombosis and Haemostasis classification, need for cardiopulmonary resuscitation or catecholamines, and death.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation

NCT04980924

Pulmonary Embolism

COMPLETED

Short-term Clinical Deterioration After Acute Pulmonary Embolism

NCT03915925

Pulmonary Embolism

COMPLETED

Pulmonary Embolism Short-term Clinical Outcomes Registry

NCT02883491

Pulmonary Embolism

COMPLETED

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

NCT05481242

Pulmonary Embolism and Thrombosis Deterioration, Clinical

ACTIVE_NOT_RECRUITING

Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy Vs. Thromboaspiration.

NCT06051032

Pulmonary Embolism and Thrombosis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Pulmonary Embolism WArsaw REgistry (PE-aWARE) is an on-going prospective observational study of patients with confirmed acute pulmonary embolism (APE). Carried out since January 2008, the registry includes consecutive patients hospitalized at a single centre. The primary data recorded include details of each patient's clinical status, co-morbidities, the prescribed treatment, the results of additional studies (ie EKG, imaging studies), and the outcome. The study endpoints comprise clinically recognized (and objectively confirmed) recurrences of PE, major and minor bleeding complications classified according to the International Society on Thrombosis and Haemostasis classification, need for cardiopulmonary resuscitation or catecholamines, and death.

Collecting the fore mentioned data allows for clinicians to better manage the diagnostic workup and treatment and thus facilitates the prevention of possible future complications in APE patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pulmonary Embolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Complicated outcome

The patients meet at least one of the following criteria:

1. systolic blood pressure \< 90 mmHg for at least 15 minutes
2. need for catecholamine administration because of persistant arterial hypotension or shock
3. need for mechanical ventilation
4. need for cardiopulmonary resuscitation
5. bleeding classified according to the International Society on Thrombosis and Haemostasis classification (major bleeding and non-major clinically relevant bleeding).

No interventions assigned to this group

Non-complicated outcome

The patients meet none of the following criteria:

1. systolic blood pressure \< 90 mmHg for at least 15 minutes
2. need for catecholamine administration because of persistant arterial hypotension or shock
3. need for mechanical ventilation
4. need for cardiopulmonary resuscitation
5. bleeding classified according to the International Society on Thrombosis and Haemostasis classification (major bleeding and non-major clinically relevant bleeding).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* objectively confirmed pulmonary embolism
* Informed consent for the participation in the study, according to the requirements of the ethics committee